Table 1.
Gene | Cases | Controls | χ 2 | P value | OR (95%CI) |
---|---|---|---|---|---|
VDR rs2228570 | 239 (100.0%) | 239 (100.0%) | 5.206 | 0.074 | |
CC | 129 (54.0%) | 114 (47.7%) | 1.883 | 0.170 | 1.286 (0.898–1.842) |
CT | 99 (41.4%) | 102 (42.7%) | 0.077 | 0.781 | 0.950 (0.661–1.366) |
TT | 11 (4.6%) | 23 (9.6%) | 4.560 | 0.033 | 0.453 (0.216–0.952) |
CC + CT dominant | 228 (95.4%) | 216 (90.4%) | 4.560 | 0.033 | 2.207 (1.051–4.636) |
CT + TT recessive | 110 (46%) | 125 (52.3%) | 1.883 | 0.170 | 0.778 (0.543–1.114) |
Allele frequency | |||||
C allele | 357 (75%) | 330 (69%) | 4.560 | 0.033 | 2.207 (1.051–4.636) |
T allele | 121 (25%) | 148 (31%) | 1.883 | 0.170 | 0.778 (0.543–1.114) |
HWE (exact) | 0.17 | 1.0 | |||
SP | 0.31 | 0.31 |
Gene | Male cases | Male controls | χ 2 | P value | OR (95% CI) |
---|---|---|---|---|---|
VDR rs2228570 | 129 (100.0%) | 129 (100.0%) | 7.962 | 0.019 | |
CC | 75 (58.1%) | 57 (44.2%) | 5.026 | 0.025 | 1.754 (1.072–2.872) |
CT | 50 (38.8%) | 59 (45.7%) | 1.287 | 0.257 | 0.751 (0.458–1.232) |
TT | 4 (3.1%) | 13 (10.1%) | 5.101 | 0.024 | 0.286 (0.091–0.901) |
Allele frequency | |||||
C allele | 200 (78%) | 173 (67%) | 5.101 | 0.024 | 3.502 (1.110–11.047) |
T allele | 58 (22%) | 85 (33%) | 5.026 | 0.025 | 0.570 (0.348–0.933) |
HWE (exact) | 0.31 | 0.84 | |||
SP | 0.51 | 0.51 |
Gene | Female cases | Female controls | χ 2 | P value | OR (95%CI) |
---|---|---|---|---|---|
VDR rs2228570 | 110 (100.0%) | 110 (100.0%) | 1.002 | 0.606 | |
CC | 54 (49.1%) | 57 (51.8%) | 0.164 | 0.686 | 0.897 (0.528–1.521) |
CT | 49 (44.5%) | 43 (39.1%) | 0.673 | 0.412 | 1.252 (0.732–2.141) |
TT | 7 (6.4%) | 10 (9.1%) | 0.574 | 0.449 | 0.680 (0.249–1.855) |
Allele frequency | |||||
C allele | 157 (71%) | 157 (71%) | 0.574 | 0.449 | 1.471 (0.539–4.017) |
T allele | 63 (29%) | 63 (29%) | 0.164 | 0.686 | 1.115 (0.657–1.893) |
HWE (exact) | 0.48 | 0.64 |
SP Statistical power, HWE Hardy–Weinberg equilibrium, VDR vitamin D receptor.